XML 51 R65.htm IDEA: XBRL DOCUMENT v2.4.0.8
LEGAL PROCEEDINGS AND CONTINGENCIES (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 12 Months Ended 1 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Baraclude [Member]
Jun. 30, 2013
Baraclude [Member]
Jun. 30, 2014
Baraclude [Member]
Jun. 30, 2013
Baraclude [Member]
Dec. 31, 2013
Baraclude [Member]
South Korea [Member]
Aug. 31, 2013
Atripla Intellectual Property Litigation [Member]
Mar. 31, 2010
Atripla Intellectual Property Litigation [Member]
Jan. 31, 2010
Atripla Intellectual Property Litigation [Member]
Apr. 30, 2009
Atripla Intellectual Property Litigation [Member]
Dec. 31, 2013
Baraclude Intellectual Property Litigation [Member]
Aug. 31, 2010
Baraclude Intellectual Property Litigation [Member]
Nov. 30, 2008
Plavix Intellectual Property Litigation [Member]
Nov. 30, 2008
Remaining Apotex Matters Related To Plavix [Member]
Jun. 30, 2014
AWP Litigation [Member]
Sep. 30, 2010
AWP Litigation [Member]
Jun. 30, 2014
Qui Tam Litigation [Member]
Jun. 30, 2014
Plavix Product Liability Litigation [Member]
Jun. 30, 2014
Reglan Product Liability [Member]
Jun. 30, 2014
Byetta Product Liability Litigation [Member]
Jun. 30, 2014
Environmental Proceedings Cercla Matters [Member]
Jun. 30, 2014
Environmental Proceedings New Brunswick [Member]
Oct. 30, 2011
Environmental Proceedings New Brunswick [Member]
May 31, 2008
Environmental Proceedings New Brunswick [Member]
Jun. 30, 2014
Environmental Proceedings North Brunswick [Member]
payment
Legal Proceedings And Contingencies [Line Items]                                                        
Number of patents owned                     6   15                              
Number of patents challenged                       8 2   1                          
Number of lawsuits                     2             2         350   500 200 300  
Number Of Interim Payments                                                       2
Number of patent infringement lawsuits                     2                                  
Settlement relating to efavirenz polymorph patents                   2                                    
Loss contingency, Estimate of possible loss                                     $ 28         $ 64        
Number of plaintiffs settled                                             510          
Number of current plaintiffs                                         6,300 3,000 1,500          
Number of sales representatives                                       3                
Litigation settlement, Gross                               60                       4
Interest percentage on damages sought by third party                                 1.00%                      
Total revenues $ 3,889 $ 4,048 $ 7,700 $ 7,879 $ 369 $ 371 $ 775 $ 737 $ 158         $ 289